Molecular (nucleic-acid based) diagnostic tests are reshaping our current approach to therapy and diagnosis in clinical practice. Compared to traditional culture method and phenotypic assay, molecular techniques offer potential for enhanced sensitivity, improved specificity, and ease of automation on common platform systems such as PCR or sequencing (Sanger or next-generation methods). This platform commonality, where a single platform can be used to assess a large number of specific assays, is a further benefit driving the increasing adoption of this class of methodology. abm is proud to present a range of test kits, from oncology to infectious disease, providing reliable and easy-to-use solutions and services to meet the needs of diagnostics laboratories in clinical research settings.